Antibiotics: Definition, Classification, Mechanism of Action, and Clinical Applications

By -

Introduction

Antibiotics are chemical substances produced by microorganisms, or synthetically prepared, that can kill or inhibit the growth of other microorganisms. They are one of the most significant discoveries in the history of medicine and have revolutionized the treatment of infectious diseases. The discovery of penicillin by Alexander Fleming in 1928 marked the beginning of the antibiotic era.

In pharmaceutical microbiology, antibiotics play a crucial role in controlling bacterial infections, ensuring product sterility, and maintaining aseptic conditions in manufacturing. However, the emergence of antibiotic resistance has become a global health concern, demanding prudent and regulated use.

Definition of Antibiotics

According to the World Health Organization (WHO), antibiotics are defined as:

“Antimicrobial substances active against bacteria and used to treat or prevent bacterial infections.”

They can be naturally produced by microorganisms (like Penicillium mold), semi-synthetic (chemically modified), or fully synthetic.

History and Discovery

The concept of using microorganisms to fight infections dates back to ancient times. However, modern antibiotics began with:

  • 1928: Discovery of Penicillin by Alexander Fleming.
  • 1940s: Large-scale production of Penicillin revolutionized World War II medical treatment.
  • 1943: Discovery of Streptomycin by Selman Waksman (effective against tuberculosis).
  • 1950s–1970s: Discovery of multiple antibiotic classes like tetracyclines, macrolides, and cephalosporins.

Classification of Antibiotics

Antibiotics can be classified in several ways — based on their spectrum of activity, mode of action, or chemical structure.

1. Based on Spectrum of Activity

  • Broad-spectrum antibiotics: Active against both Gram-positive and Gram-negative bacteria (e.g., Tetracycline, Chloramphenicol, Amoxicillin).
  • Narrow-spectrum antibiotics: Active against specific bacterial types (e.g., Penicillin G effective mainly against Gram-positive bacteria).

2. Based on Mode of Action

Antibiotics target essential bacterial processes to stop growth or cause cell death:

Mode of Action Target Site Examples
Inhibition of cell wall synthesis Peptidoglycan layer Penicillins, Cephalosporins, Vancomycin
Inhibition of protein synthesis Ribosomal subunits (30S or 50S) Tetracyclines, Macrolides, Aminoglycosides
Inhibition of nucleic acid synthesis DNA/RNA synthesis enzymes Fluoroquinolones, Rifampicin
Disruption of cell membrane Phospholipid bilayer Polymyxins, Daptomycin
Inhibition of metabolic pathways Folate synthesis Sulfonamides, Trimethoprim

3. Based on Chemical Structure

Antibiotics can also be grouped by their chemical backbone:

  • β-lactam antibiotics: Penicillins, Cephalosporins, Carbapenems
  • Aminoglycosides: Streptomycin, Gentamicin
  • Macrolides: Erythromycin, Azithromycin
  • Tetracyclines: Doxycycline, Minocycline
  • Fluoroquinolones: Ciprofloxacin, Levofloxacin
  • Glycopeptides: Vancomycin, Teicoplanin
  • Polypeptides: Bacitracin, Polymyxin B

Mechanism of Action of Antibiotics

Antibiotics interfere with vital bacterial processes to stop their growth or cause death. The mechanisms include:

  • Inhibition of Cell Wall Synthesis: β-lactam antibiotics block the synthesis of peptidoglycan, leading to bacterial lysis.
  • Inhibition of Protein Synthesis: Macrolides and tetracyclines bind to bacterial ribosomes, halting protein formation.
  • Disruption of Cell Membrane: Polymyxins disrupt bacterial membrane integrity, causing leakage of contents.
  • Inhibition of Nucleic Acid Synthesis: Quinolones inhibit DNA gyrase or topoisomerase enzymes.
  • Inhibition of Metabolic Pathways: Sulfonamides inhibit folic acid synthesis, essential for bacterial growth.

Clinical Applications of Antibiotics

Antibiotics are used in a wide range of medical and pharmaceutical applications:

  • Treatment of bacterial infections: Pneumonia, tuberculosis, urinary tract infections, and sepsis.
  • Prophylactic use: Preventing infections during surgeries or in immunocompromised patients.
  • Topical use: Antibiotic ointments and creams for wound healing and skin infections.
  • Veterinary use: Prevention of bacterial diseases in animals.
  • Pharmaceutical manufacturing: Used in quality control and contamination prevention in bioprocesses.

Antibiotic Resistance

The misuse and overuse of antibiotics have led to the rise of antibiotic-resistant bacteria, posing a major threat to global health. Bacteria acquire resistance through:

  • Genetic mutations in target sites
  • Plasmid-mediated gene transfer
  • Enzymatic degradation of antibiotics (e.g., β-lactamases)
  • Efflux pumps that expel antibiotics from bacterial cells

Examples of Resistant Bacteria

  • MRSA: Methicillin-resistant Staphylococcus aureus
  • VRE: Vancomycin-resistant Enterococcus
  • ESBL: Extended-spectrum β-lactamase-producing bacteria
  • MDR-TB: Multidrug-resistant Mycobacterium tuberculosis

Strategies to Prevent Antibiotic Resistance

  • Rational and prescribed use of antibiotics
  • Avoiding unnecessary antibiotic use in viral infections
  • Implementation of antibiotic stewardship programs
  • Development of new antibiotics and alternative therapies
  • Public awareness and regulatory control in pharmaceutical industries

Recent Advances and Future Outlook

Research continues to explore new ways to overcome antibiotic resistance, including:

  • Development of novel antibiotics and β-lactamase inhibitors
  • Use of bacteriophages (viruses that kill bacteria)
  • Probiotics and prebiotics as natural alternatives
  • CRISPR-based antimicrobial gene therapy

Conclusion

Antibiotics remain one of the greatest achievements in medical science, saving countless lives worldwide. However, the growing threat of antibiotic resistance calls for responsible usage, continuous surveillance, and innovation in antibiotic discovery. Pharmaceutical microbiology continues to play a vital role in ensuring the safety, quality, and efficacy of antibiotic products for sustainable healthcare.

💬 About the Author

Siva Sankar is a Pharmaceutical Microbiology Consultant and Auditor with extensive experience in sterility testing, validation, and GMP compliance. He provides consultancy, training, and documentation services for pharmaceutical microbiology and cleanroom practices.

📧 Contact: siva17092@gmail.com
📱 Mobile: 09505626106

Disclaimer: This article is for educational purposes and does not replace your laboratory’s SOPs or regulatory guidance. Always follow validated methods and manufacturer instructions.

Popular posts from this blog

Non-Viable particle count (NVPC)

By -
Image
Particle mater in room air limits are in particles of 0.5 μm and larger per cubic meter. ISO = cubic meter (m 3 ) FD Standard 209 E = cubic feet (ft 3 )   ISO class equal to federal standard 209 E class .  1m 3  = 35.31 ft 3 1m = 100 cm Adapted from former Federal Standard No. 209 E,                ISO = international organization for standard 14644 part -1, may -1999 p ublished. Maximum concentration limits (particles M3 of air) for particles equal to and larger than the considered sizes shown below: (a) ISO Classification Number(N) 0.1µm 0.2µm 0.3µm 0.5µm 1.0µm 5.0µm ISO 1 b                    10 d                 2 d d d e ISO 2 10...
Read more

Alert and Action Limits

By -
In pharmaceuticals alert and action limits are very important, because these limits are effective control to the process. alert and action limits are in house limits, these limits must be less than guideline limits or define limits. Alert and action limits defined based on trend analysis. alert and action limits are like a barrier before the guideline limits. Alert Limit: To be alert the microbial counts reach to this alert level. It is nor necessary to take any action. Possible deviation from normal process condition This is a trigger, that something is going wrong means microbial count increasing that area. Action Limits: When microbial count reach this action limits then action is mandatory. To control the  microbial count in the area. Signal an apparent deviation from normal process condition And require immediate action. If not controlled, we might get area failure. These alert and action limits must be less than final limits. Example : A...
Read more

TNTC vs TFTC

By -
Image
Too Numerous To Count (TNTC) or Too Many To Counts (TMTC) In samples with very high bacterial concentration, that is not suitable for counting (unable to get accurate counts) and reports the results as "to numerous to count" (TNTC). While the best solution is to collect another sample and dilute to get a more accurate counts, this might not always to be possible. Ideally one plate with 200 to 250 colonies are used. Counts above 250 are considered "to numerous to count" (TNTC), because it is impossible to count the colonies. plates countable range 25 to 250. Too Few To Count (TFTC): If there are less than 30 colonies on the plate, small errors in dilution technique or the presence of a few contaminants will have a drastic effect on the final count this count is called too few to count (TFTC).
Read more